AeroVironment, Inc. (AVAV) specializes in unmanned aircraft systems, loitering munitions like Switchblade, and counter-drone plus directed-energy technologies. Shares climbed above $417 late in 2025 before dropping more than 40% and hovering near the 52-week low of $135.20 through much of 2026. A post-earnings recovery has pushed the stock back into the mid-$150s, prompting fresh discussion on whether it can return to the $200 threshold.
After releasing fiscal first-quarter results in September 2026, AeroVironment (AVAV) traded around $153, reflecting an approximate strong performance as the market absorbed the numbers. Revenue reached roughly $480.5 million, ahead of consensus near $456 million, while adjusted EPS came in at $0.59 compared with expectations of about $0.24. The funded backlog hit a record $1.5 billion, up 37% from a year earlier, and the book-to-bill ratio stood at 1.4, pointing to solid demand for counter-UAS and autonomous offerings. Management kept fiscal 2027 guidance intact at $2.125–$2.225 billion in revenue and adjusted EPS of $3.02–$3.34, though most of the activity is expected in the second half.
One standout development is the company’s directed-energy work. In early September 2026 it received a $464.8 million U.S. Army contract for the LOCUST X3 laser weapon system under the Enduring-High Energy Laser program—the first production award of its kind. An initial international LOCUST order followed, hinting at wider market reach. The BlueHalo acquisition has added exposure to space, cyber, and electronic warfare, enlarging the addressable market. Ongoing demand for counter-drone solutions, fueled by battlefield trends, supports a constructive backdrop. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Fundamentals are still mixed. Trailing net losses stand near $265 million with a negative net margin, so the valuation rests on future expectations. The forward P/E in the low-to-mid 40s leaves little margin for error if the second-half ramp falters. Execution and governance issues persist, including a goodwill impairment from a terminated program and a material weakness in internal controls that remains under remediation. A lost U.S. Space Force contract earlier in 2026 highlights award volatility, and negative free cash flow is anticipated in fiscal 2027 as capacity investments continue.
Wall Street sentiment stays mostly positive despite several target cuts in 2026. The consensus leans toward Buy or Moderate Buy, with average 12-month targets between $224 and $267 and individual figures ranging from $166 to $429. Recent updates include J.P. Morgan lifting its target to $210, Citizens JMP holding at $230, and Raymond James keeping an outperform rating with a $210 objective. The $200 level sits below the consensus average yet above some more cautious estimates, placing it within the range of outcomes analysts currently foresee.
From a technical standpoint, the 52-week low near $135.20 serves as key support where buyers have stepped in repeatedly. On the upside, reclaiming $180 would be the first hurdle before testing $200, which aligns with the lower end of several analyst targets. With a beta around 1.41, the shares tend to move more sharply than the broader market.
Traders following names like AeroVironment (AVAV) can benefit from AI Daily Buy/Sell Signals to stay on top of shifting conditions. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals drawn from market dynamics, technical patterns, and data-driven models. It helps surface fresh ideas, track open positions, and spot emerging trends. I find it useful as a complement to my own review of backlog trends and contract updates.
A move toward $200 looks achievable for AeroVironment (AVAV) yet remains uncertain. Support comes from the record backlog, the historic laser contract, and analyst targets that generally exceed that mark. Offsetting factors include ongoing losses, the back-loaded revenue outlook, governance work, and near-term cash-flow pressure. Watching backlog expansion, margin trends, the timing of second-half deliveries, and progress on controls will be key before assuming the stock can hold above $200.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AVAV declined for three days, in 235 of 318 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVAV as a result. In 56 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for AVAV turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 36 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
The Aroon Indicator for AVAV entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +24.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in 242 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
AVAV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.304) is normal, around the industry mean (5.050). P/E Ratio (-27.773) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (1.565) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (3.893) is also within normal values, averaging (18.367).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of unmanned aircraft and charging systems
Industry AerospaceDefense